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A novel, simple, accurate and precise RP-HPLC method for simultaneous determination of levosalbutamol 
sulfate and theophylline has been developed and validated. Separation was achieved on a Phenomenex; C18 
column (250 mm × 4.6 mm i.d., 5 μm) using methanol: 10 mM TBAHS(tetrabutyl ammonium hydrogen 
sulfate) (50:50, v/v) as mobile phase at flow rate of 1.0 mL.min-1. The UV detection wavelength was 
274 nm. The linearity is obeyed over a concentration range of 0.5-150 μg.mL-1 with correlation coefficient 
of 0.999 for both the drugs. The proposed method was validated by determining accuracy, precision, 
stability and system suitability parameters. The method was found to be robust. Specificity of the method 
was determined by subjecting the drugs to various stress conditions like acid, alkali, oxidation, thermal 
and photolytic degradation. The method was used successfully for the simultaneous determination of 
levosalbutamol sulfate and theophylline in syrup dosage form. 
Uniterms: Levosalbutamol/determination. Theophylline/determination. Stability-indicating. RP-High 
performance liquid chromatography/qualitative analysis Syrup/qualitative analysis.
Desenvolveu-se e validou-se método de RP-HPLC novo, simples, exato e preciso de determinação 
simultânea do sulfato de levossalbutamol e teofilina.. A separação foi efetuada em uma coluna 
Phenomenex; C18 (250 mm x 4,6 mm d.i., 5 μm) utilizando metanol: TBAHS (hidrogenossulfato de 
tetrabutilamônio) 10 mM (50:50, v/v) como fase móvel, com fluxo de 1,0 mL.min-1. O comprimento de 
onda de detecção no UV foi 274 nm. Observou-se linearidade na faixa de concentração de 0,5-150 μg mL-1, 
com coeficiente de correlação de 0,999 para ambos os fármacos. O método proposto foi validado 
determinando-se exatidão, precisão, estabilidade e parâmetros de adequação do sistema. O método 
mostrou-se robusto. A especificidade do método foi determinada submetendo os fármacos a várias 
condições de estresse, como ácido, álcali, oxidação, degradação térmica e fotolítica. O método foi usado 
com sucesso para a determinação simultânea do sulfato de levossalbutamol e teofilina na forma de xarope.
Unitermos: Levosalbutamol/determinação. Teofilina/determinação. Indicador de estabilidade.  
RP-Cromatografia líquida de alto desempenho. Xarope/análise qualitativa
INTRODUCTION
Levosalbutamol sulfate (levalbuterol), (R)-α´-[(tert-
butylamino)-4-hydroxy-m-xylene-αα´-diol sulfate(2:1) is 
a bronchodilator indicated for management of asthma. It 
is preferred over racemic salbutamol sulfate for increased 
efficacy and safety after use (Berger, 2003). Theophylline, 
3,7-dihydro-1,3-dimethyl purine-2,6(1H)-dione is a 
xanthine derivative used for management of asthma and 
related obstructive respiratory conditions(Persson,1986).
The chemical structure of both the drugs are shown in 
Figure 1.
Literature review shows that no stability-indicating 
RP-HPLC methods are present so far for simultaneous 
estimation of levosalbutamol sulfate and theophylline 
in combined syrup dosage form using methanol: 10 mM 
TBAHS (tetra butyl ammonium hydrogen sulfate) as the 
mobile phase. Some of the reported methods for racemic 
salbutamol sulfate includes titrimetric (Basavaiah et al., 
2006, 2007), potentiometric (Abdel-Ghani et al., 2002), 
spectrophotometric (Basavaiah et al., 2003, 2006, 2007; 
Chitlange et al., 2011; Culzoni et al., 2006; Geeta et 
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FIGURE 1 - Chemical Structure of (A) levosalbutamol sulfate 
and (B) theophylline.
al., 1989; Habib et al., 2004; Jain et al., 2011; Mishra 
et al., 2010; Parimoo et al., 1993; Rathore et al., 1993), 
spectrofluorimetric (Pandya et al., 2010), HPLC (Bernal 
et al., 1996; Boulton et al., 1995; Chitlange et al., 2011; 
Erram et al., 2006; Jain et al., 2011; Kasawar et al., 2010; 
Kountourellis et al., 1990; Martis et al., 2011; Murtaza 
et al., 2009; Pai et al., 2009) and LC-MS(Joyce et al., 
1998; Wu et al., 2004, 2011; Yee et al., 2011). Whereas 
for levosalbutamol sulfate a few spectrophotometric 
(Prasanna et al., 2012; Thulasama et al., 2009) and HPLC 
(Ghemud et al., 2012; Halabi et al., 2004; Prasanna et 
al., 2012) methods are reported. The reported methods 
for theophylline includes spectrophotometric (Abuirjeie 
et al., 1992; Bermejo et al., 1985; Carter et al., 1985; 
Fellenberg et al., 1979; Hohnadel et al., 1978; Jatlow, 
1975; Kumar et al., 2011; Plavsic, 1978; Vasiliades et al., 
1976), HPLC (Abuirjeie et al., 1992; Boberic-Borojevic et 
al., 1999; Greenberg et al., 1979; Lauff, 1987; Moncrieff, 
1991; Papadoyannis et al., 1993; Shidhaye et al., 2009), 
GC (Chrzanowski et al., 1974; Schwertner, 1979; Shah 
et al., 1974) and LC-MS (Abdel-Hamid et al., 2003; 
Babu et al., 2011; Kanazawa et al., 2000; Song et al., 
2004). The literature survey suggests there is lack of a 
stability indicating RP-HPLC method for simultaneous 
determination of levosalbutamol sulfate and theophylline 
in combined syrup dosage forms. Only one RP-HPLC 
method has been reported so far for simultaneous 
estimation of the racemic salbutamol sulfate and 
theophylline in combined tablet dosage form (Maithani et 
al., 2011). But the reported method has several drawbacks 
like maintaining pH of buffer, increased retention times 
of the drugs, narrow range of linearity and higher mobile 
phase flow rate etc. So, an attempt was made to overcome 
these drawbacks and develop a novel, simple, accurate 
and precise, stability-indicating RP-HPLC method for 
simultaneous determination of levosalbutamol sulfate and 
theophylline in syrup dosage form. To prove the stability-
indicating nature of the method forced degradation of drug 
substances and drug product was performed under stress 
conditions (acid, alkali, oxidation, thermal and photolysis), 
and the stressed samples were analyzed by the developed 
method. The method was also validated according to 
requirements of ICH (International Conference on 
Harmonization of Technical Requirements for Registration 
of Pharmaceuticals for Human Use, 2005) guideline.
MATERIAL AND METHODS
Material
Methanol used was of HPLC grade (Merck Ltd., 
Mumbai, India).Water for chromatography was obtained 
using TKA water purification system (Germany).
Standard drug of levosalbutamol sulfate (purity>99.5%) 
and theophylline (purity>99%) were received from 
Cipla Ltd., India and Glenmark Pharmaceuticals Ltd., 
India, respectively. AR grade Tetra Butyl Ammonium 
Hydrogen Sulfate (TBAHS) was procured from HiMedia 
Laboratories Pvt. Ltd., India. Marketed syrup formulation 
was bought from the local market.
Chromatographic conditions
Quantitative HPLC was performed on a binary 
gradient HPLC with Shimadzu LC-10AT and LC-10AT VP 
Series HPLC pumps, with a 20 µL sample injection loop 
(manual) and SPD 10A VP series UV-Visible detector. The 
signal was monitored and integrated using Shimadzu Class-
VP Version 6.12 SP1 Software. A Phenomenex; C18 column 
(250 mm× 4.6 mm i.d., 5 μm) was used for separation. 
Methanol: 10 mM TBAHS in the ratio (50:50, v/v) was 
used as the mobile phase. The 10 mM TBAHS solution 
was prepared by accurately weighing 3.3954 g of TBAHS 
salt and dissolving it in 1000 mL of HPLC grade water. 
Afterwards, both the methanol and TBAHS solution were 
ultrasonicated up to 30 min for degassing and were filtered 
through a 0.45 µm membrane filter, prior to use. The flow 
rate was 1.0 mL.min-1 and UV detection was carried out at 
274 nm. The separation was achieved at room temperature.
Preparation of standard stock solution
Standard stock solutions for both the drugs were 
prepared separately by dissolving 25 mg of drugs in 
mobile phase up to 25 mL. The volumetric flasks having 
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10 mL of mobile phase with the drugs were shaken and 
finally volume was made up to get a concentration of 
1000 µg.mL-1. Both the standard drug solutions were 
filtered through a 0.2 µm membrane filter. The stock 
solutions were stored at 2-8 ºC.
Method validation 
Linearity and preparation of analytical curve
Suitable aliquots of the standard stock solutions of 
levosalbutamol sulfate (1000 µg.mL-1) and theophylline 
(1000 µg.mL-1) were transferred into a series of 10 mL 
volumetric flasks to get final concentrations of 0.5, 1.0, 5.0, 
10, 20, 40, 80,100,150 μg.mL-1(9 points). Final volume 
was made up with mobile phase. Each mixed standard 
solution was injected and chromatograms were recorded. 
The linearity of analytical curves was plotted for peak area 
of each drug against concentrations of drug.
Analysis of syrup dosage form
Five mL of the syrup containing levosalbutamol 
sulfate and theophylline equivalent to 5mg and 50mg 
of the standard drugs respectively was measured 
accurately and dissolved in 50 mL of mobile phase. It 
was ultrasonicated for 25 minutes and volume was made 
up with the mobile phase, followed by filtration through 
0.2 µm membrane filter. The syrup solution was further 
diluted with the mobile phase to get sample solutions 
within the linearity range. The sample solutions were 
injected and chromatograms were obtained. The amount 
of drug present in the sample solution was calculated using 
the analytical curves of standard drugs.
Precision
The precision (intraday and interday) of the 
method was ascertained from the peak areas obtained by 
determination of six replicates of fixed amount of drugs. 
The system precision was ascertained by carrying out six 
injections of a fixed amount of drug solution. The percent 
relative standard deviations were calculated.
Accuracy
To check the accuracy of the proposed method, 
recovery studies were carried out at 80, 100 and 120% of 
the test concentration according to ICH guidelines. The 
recovery study was performed three times at each level.
Robustness
Robustness of the method was studied by deliberately 
changing the UV detection wavelength (±5 nm), mobile 
phase flow rate (±0.2 mL) and organic phase composition 
(±5%).The effect was studied in terms of various system 
suitability parameters like retention time, resolution, 
theoretical plates and tailing factor for both the drugs. 
Solution stability study was also carried out by keeping 
the sample solutions at 25±2 ºC for 24 h.
Forced degradation study
Specificity of the method was determined by 
checking interference of any of the possible degradation 
products produced during the forced degradation study. 
The forced degradation was carried out with 0.1 M HCl, 
0.1 M NaOH, 3% v/v hydrogen peroxide, thermal (80 ºC) 
and photolysis (365 nm) for finding out the stability nature 
of the drugs. The degradation samples were prepared 
by taking suitable aliquots of the drug and drug product 
solutions, and then undertaking the respective stress 
testing procedures for each solution. After the fixed 
time period the treated drug solutions were diluted with 
mobile phase. For every stress condition three solutions 
were prepared as 1 µg.mL-1 of levosalbutamol sulfate, 
10 µg.mL-1 of theophylline and drug product solution 
containing 1 µg.mL-1 of levosalbutamol sulfate with 
10 µg.mL-1 of theophylline. The specific stress conditions 
are described as follows.
A) Acidic degradation
Acidic degradation was carried out by adding 1.0 mL 
of 0.1 M HCl, and after 1hr neutralizing the mixture by 
adding 0.1 M NaOH.
B) Alkali degradation
Alkali degradation was carried out by adding 1.0 mL 
of 0.1 M NaOH, and after 1 h neutralizing the mixture by 
adding 0.1 M HCl.
C) Oxidative degradation
Oxidative degradation was performed by exposing 
the drug to 1.0 mL of 3% (v/v) H2O2 1 h.
D) Thermal degradation
Thermal degradation was performed by heating the 
drug solutions at 80 ºC on a thermostatically controlled 
water bath for 1 h.
E) Photolytic degradation condition
Photolytic degradation was carried out by exposing 
the drug solutions to UV light (365 nm) inside an UV 
chamber for 5 h.
System suitability
The System Suitability was calculated for different 
parameters like theoretical plates, resolution, tailing factor, 
LOD and LOQ. The LOD and LOQ were separately 
determined based on the Signal to Noise ratio. For LOD 
the S/N ratio is 3:1.For LOQ the S/N ratio is 10:1.
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RESULTS AND DISCUSSION
Method development and optimization 
Method development process was carried out 
by examining conditions like flow rate (0.8 mL.min-1, 
1.0 mL.min-1 and 1.2 mL.min-1), mobile phase compositions 
like acetonitrile:water, acetonitrile:buffer, methanol:water, 
methanol: 10 mM TBAHS and ratios (50:50, 60:40 and 
45:60, v/v) were used. Both the drugs levosalbutamol 
sulfate and theophylline were found showing a significant 
UV absorbance at 274 nm in methanol: 10 mM TBAHS 
(50:50, v/v), so this wavelength was chosen for UV 
detection. By use of a C18 column it was found the mobile 
phase consisting of methanol: 10mM TBAHS (50:50, v/v) 
provided well defined peak shape with good resolution. 
Levosalbutamol sulfate was eluted at 2.558 min where 
as theophylline eluted at 4.867 min. The representative 
chromatograms of pure drug and combined drug product 
are shown in Figure 2 (A) and (B), respectively.
Method validation
Linearity
Levosalbutamol sulfate and theophylline have 
linearity over concentrations ranging from 0.5 to 
150.0 µg.mL-1. The slope (a) and intercept (b) were found 
to be 6103 and 4583 for levosalbutamol sulfate and 63827 
and -2793 for theophylline. Correlation coefficient (r2) was 
found to be 0.999 for both the drugs. These results suggest 
a good linear relationship between peak area and analytes 
in the range studied.
Analysis of syrup dosage forms
The % recovery was more than 100% for syrup 
dosage form. Good % recovery and noninterference 
in separation of both the drugs because of formulation 
components suggests that; the method is selective and 
excipients present in the formulation have no affect in the 
determination. The results are given in Table I.
Precision
The RSD for method (intraday and interday) and 
system precision were found to be less than 2% showing 
high degree of preciseness as shown in Table II.
Accuracy
Accuracy was checked by preparing mixtures 
containing different amounts of pure drugs and fixed 
amount of formulation; analyzing the mixtures by use 
FIGURE 2 - Representative chromatograms of levosalbutamol sulfate and theophylline. (A) combined standard drugs[ratio 1:1]
(B) combined formulation[ratio 1:10].
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TABLE I - Analysis of syrup dosage form
Formulation
Type Labeled Amount (mg)
Recovery by proposed methoda (%)±S.D.,
R.S.D (%)
Levosalbutamol sulfate Theophylline
Syrup
Each 5 mL contains 
levosalbutamol sulfate≈5 mg
theophylline≈50 mg
101.6±1.4106,
1.38
101.43±0.9237,
0.91
a average of three determinations
TABLE II - Intraday, interday and system precision studies(n=6)
Type of Study
Concentration Taken (μg.mL-1) Peak Areab ±Standard Deviation,(%RSD)
Levosalbutamol Sulfate Theophylline Levosalbutamol sulfate Theophylline
Intraday precision
Interday precision
20
20
20
20
125306.83±
260.13,0.21
126566±
356.59,0.28
1246288±
4391.99,0.35
1246723±
3592.9,0.29
System precision 20 20 126234.16±
366.88,0.29
1264023±
3545.68,0.28
b average of six determinations
TABLE III - Accuracy of the method
Different concentration 
level comparing to sample 
concentration (%)
Amount Added
Pure Drug
(µg.mL-1)
Recoveryc(%) 
Pure Drug
±SD, RSD (%)
Levosalbutamol Sulfate Theophylline Levosalbutamol Sulfate Theophylline
80
100
120
4
5
6
40
50
60
100.5±0.4330,0.43
100.43±0.1571,0.16
100.33±0.33,0.33
101.11±0.5478,0.54
100.61±0.2402,0.24
100.81±0.4463,0.44
c average of three determinations at each level
of developed method. Percentage recovery and relative 
standard deviation were also calculated. The results 
obtained suggest the recoveries were excellent, and 
relative standard deviations were less than 2%.The results 
of recovery study are given in Table III.
Robustness
The method was found to be robust under deliberate 
changes made in mobile phase flow rate, composition 
of organic phase and UV detection wavelength. Various 
system suitability parameters were evaluated to find out the 
robustness of the method. The results for system suitability 
parameters are presented in Table IV. The results of solution 
stability for both the drugs was satisfactory with a recovery 
more than 99% after 24 h, showing no significant loss of the 
analytes in the selected mobile phase.
Specificity
Specificity of the method was ascertained by checking 
any interference because of excipients or degradation 
products produced after subjecting levosalbutamol sulfate 
and theophylline to forced degradation. No extra peaks 
were obtained either from the excipients used in the drug 
product or from the stress conditions applied on the drugs 
and drug product. Therefore the method was found specific 
and stability-indicating. Forced degradation conditions 
were optimized in order to get degradation of the drugs 
up to 30%. The stress conditions like 0.1 M HCl, 0.1 M 
NaOH, 3% v/v H2O2, 80 ºC temperature and 365 nm UV 
radiation were applied to check the degradation nature of 
the drugs. Levosalbutamol sulfate undergoes significant 
degradation (34.15%) in oxidative stress, moderate 
degradation in alkaline (5.64%) and thermal (3.67%) 
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stress conditions. Levosalbutamol was found to be 
stable in the applied acidic and UV stress conditions. 
The drug theophylline was found to be more stable 
towards the applied stress conditions than compared 
to levosalbutamol. Theophylline undergoes moderate 
degradation in alkaline (7.57%) and oxidative (2.47%) 
stress conditions, and the drug was found to be stable 
in the applied acidic, thermal and UV stress conditions. 
Figure 3-(A), (B),(C),(D),(E) and (F) represents 
the chromatograms of untreated drugs; acid, alkali, 
oxidation, thermal and photolysis degraded drugs with 
combined drug product, respectively.
System suitability
A critical evaluation of the method was performed. 
A higher resolution value indicates better separation of 
both the drugs. Also the LOD and LOQ values show 
superior sensitivity of the method. The System suitability 
parameters are shown in Table V. 
CONCLUSION
This simple and accurate RP-HPLC method has been 
developed and validated for determining levosalbutamol 
sulfate and theophylline in syrup dosage form. Lack of 
a stability-indicating method for determination of both 
the drugs in a combined syrup dosage form is the driving 
cause for development of this novel method. The sample 
preparation technique is also very simple for the syrup 
dosage form making it suitable for routine laboratory 
testing. Major advantage of this method is the analytes 
do not interfere with each other’s elution with a good 
difference in retention times. Specificity study carried out 
by forced degradation ensures that the method is specific 
and able to describe the stability nature of both the drugs 
in a combined drug formulation. The mobile phase is 
simple to prepare. Results of precision study demonstrate 
the superior preciseness of the method as the RSD values 
were well within the limits. The recovery value of more 
than 100% shows higher levels accuracy of the method. 
So it can be concluded that the developed RP-HPLC 
method is novel, simple, accurate, precise, sensitive, and 
stability-indicating and can be employed successfully 
for the simultaneous determination of levosalbutamol 
sulfate and theophylline in syrup dosage form. Further 
the developed method may be applied for bioavailability 
and bioequivalence study of both the drugs in different 
biological samples.
TABLE IV- Robustness of the method
Parameter
RetentionTime(Rt),min
Resolution 
(Rs)
Theoretical Plates(N) Tailing Factor(T)
Levosalbutamol 
sulfate Theophylline
Levosalbutamol 
sulfate Theophylline
Levosalbutamol 
sulfate Theophylline
Flow rate
(mL.min-1)
0.8
1.0
1.2
Methanol
(%)
45
50
55
Wavelength
(nm)
269
274
279
3.167
2.575
2.142
2.592
2.575
2.533
2.575
2.575
2.558
6.042
4.967
4.083
5.433
4.967
4.483
4.975
4.967
4.875
5.75
5.98
5.54
6.31
5.98
5.57
6.0
5.98
5.79
2938
2926
2838
2899
2926
2992
2941
2969
2895
5945
5989
5427
5685
5989
5673
5900
5989
5695
1.39
1.36
1.36
1.31
1.36
1.31
1.31
1.36
1.34
1.33
1.33
1.33
1.39
1.33
1.36
1.34
1.33
1.37
TABLE V- System suitability
Parameter
Obtained Values
Levosalbutamol 
sulfate Theophylline
Retention time
Theoretical plates
Tailing factor
Resolution
LOD(µg.mL-1)
LOQ(µg.mL-1)
2.558
2926
1.36
---
0.16
0.54
4.867
5989
1.33
5.94
0.015
0.051
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FIGURE 3A - Representative chromatograms of untreated drugs. Each chromatogram represents (i) levosalbutamol sulfate 
(1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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FIGURE 3B - Representative chromatograms of acid degraded drugs. Each chromatogram represents (i) levosalbutamol sulfate 
(1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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FIGURE 3C - Representative chromatograms of alkali degraded drugs. Each chromatogram represents (i) levosalbutamol sulfate 
(1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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FIGURE 3D - Representative chromatograms of oxidation degraded drugs. Each chromatogram represents (i) levosalbutamol 
sulfate (1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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FIGURE 3E - Representative chromatograms of thermally degraded drugs. Each chromatogram represents (i) levosalbutamol 
sulfate (1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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FIGURE 3F - Representative chromatograms of photolysed drugs. Each chromatogram represents (i) levosalbutamol sulfate 
(1 μg.mL-1), (ii) theophylline (10 μg.mL-1), (iii) dosage form having levosalbutamol sulfate (1 μg.mL-1) and theophylline 
(10 μg.mL-1).
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